A Calix securities class action filed May 27 in federal court names the company’s CEO and CFO as individual defendants, alleging that Calix quietly enjoyed inflated margins by stocking up on cheap memory components, then hid the fact that the stockpile was running out. The case, Noor v. Calix, Inc. et al, No. 5:26-cv-04993, was filed in the U.S. District Court for the Northern District of California.
| Detail | Value |
|---|---|
| Class period | January 28, 2026 – April 21, 2026 |
| Lead plaintiff deadline | July 27, 2026 |
| CALX drop on earnings day | ~13.98% ($49.58 to $42.65) |
| Q1 2026 non-GAAP gross margin | 57.2% (down 80 bps sequentially) |
| Q2 2026 non-GAAP gross margin guidance | 54.25% – 57.25% |
| Individual defendants | CEO Michael Weening, CFO Cory Sindelar |
What the Calix Securities Class Action Alleges
The complaint names CEO Michael Weening and CFO Cory Sindelar alongside the company itself. Plaintiffs allege that during the class period, Calix management made positive statements about margins, operations, and business prospects while concealing that the favorable margin performance depended on an advanced purchase of memory components bought before prices rose.
According to the Scott+Scott case page, Calix’s CFO acknowledged on the April 21 earnings call that “advanced purchasing had allowed us to avoid higher memory component costs during the first quarter” and that the advanced supply had “run its course.” From that point forward, Calix would be buying memory at rising market prices. Plaintiffs argue management knew this dynamic was developing well before investors did.
The lawsuit also takes aim at Calix’s Form 10-K risk factor disclosures, filed February 20, 2026. Those disclosures warned that component shortages “could” disrupt the business. Plaintiffs allege the language was misleading because, by filing date, the risks had already materialized rather than remaining hypothetical.
The Margin Numbers Behind the Lawsuit
When Calix posted Q1 2026 results on April 21, the revenue figure looked strong. Revenue came in at a record $280.0 million, up 3% sequentially and 27% year-over-year. The company also ended the quarter with $243.3 million in cash and investments, even after repurchasing 3.3 million shares for $170.9 million.
But the margin picture told a different story. Q1 non-GAAP gross margin came in at 57.2%, down 80 basis points from the prior quarter. Then came the forward guidance: Q2 non-GAAP gross margin of 54.25% to 57.25%, a wide range with the low end representing a sharp drop.
For the full year, Calix guided non-GAAP gross margin to decline between 50 and 150 basis points. The company’s Q1 2026 stockholder letter on SEC.gov cited a 200-basis-point headwind from surcharges tied to higher memory costs. The market reacted immediately. According to the Levi & Korsinsky case summary, CALX fell approximately 13.98% the next trading session, dropping from $49.58 to close at $42.65 on April 22, on unusually heavy volume.
Calix filed its Form 10-Q for the quarter ended March 28, 2026 on April 22, the same day the stock sold off. The company’s stock repurchase program had a remaining authorized balance of $63.4 million as of March 28, 2026.
What Shareholders Should Know Now
The Calix securities class action covers purchases made between January 28, 2026 and April 21, 2026. Anyone who bought CALX during that window may be eligible to participate. No class has been certified yet, which means shareholders are not currently represented by any law firm unless they have retained one independently.
Investors do not need to serve as lead plaintiff to potentially recover damages. But those who want to seek the lead plaintiff role must move the court by July 27, 2026. That is the hard deadline.
Multiple firms have filed related actions, so shareholders evaluating whether to join should compare counsel options before the deadline. The Calix securities class action now has competing filings from Rosen Law Firm, Glancy Prongay, and Scott+Scott, among others.
The central factual question, whether Calix management knew the memory component buffer was nearly depleted before making upbeat margin statements, is what a court will ultimately need to resolve. Q2 results, expected later this summer, will show whether the 54.25% to 57.25% gross margin guidance proves accurate or worse, and that data point will sharpen the picture for both plaintiffs and the defense.
